SCHEMBL5698441

SCHEMBL5698441

CSc1ccc(C=C(C(C)=O)c2ccncc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.57
AKR1C2 P52895 3/20 0.57
AKR1C1 Q04828 3/20 0.57
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
CASP3 P42574 1/20 0.39
RAB9A P51151 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5698436 1.00 AKR1C3 (0.57) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL6169890 0.84 AKR1C1 (0.79) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL6169895 0.84 AKR1C1 (0.79) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL6514404 0.82 AKR1C3 (0.57) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL6514407 0.82 AKR1C3 (0.57) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL5698531 0.81 AKR1C3 (0.49) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL5698524 0.81 AKR1C3 (0.49) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL6168027 0.81 AKR1C3 (0.69) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL6168025 0.81 AKR1C3 (0.69) AKR1C3AKR1C2AKR1C1SMN1; SMN2MAPT
SCHEMBL5253681 0.81 AKR1C1 (0.55) AKR1C3AKR1C2AKR1C1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed